European Commission: FP7
  • Developing new therapies
  • Enhancing individual therapies
  • Improving clinical diagnostics
  • Understanding mechanisms of pain

Multidisciplinary partners, one goal: Enhanced pain prevention and relief

The ncRNAPain consortium seeks to identify and validate specific ncRNAs that could serve as basis for the development of new drugs for pain prevention and relief. Diagnostic tools developed in the course of the project will enable better patient stratification, improved treatment, and targeted prevention strategies for high risk individuals. ncRNAPain thus aims to provide a major advancement in the knowledge of how pain is generated, propagated and relieved, and in evidence-based pain diagnosis and treatment.

In order to achieve this ambitious goal, ncRNAPain brings together a multidisciplinary project consortium of leading molecular and systems-level neuroscientists and bioinformatics as well as ncRNA experts and clinical partners from eleven European partner institutions.